Results
ADVERSE EVENTS
Eighty (31%) patients were eligible, 57 (71%) consented, 54 randomised
(40:13, +1 exclusion) and 39 (74%) completed 12-week outcomes. Treatment
fidelity was good: participants received median eight intervention sessions
(IQR: 5, 12) lasting 4.7 min (IQR: 4.1, 5.0). All six serious adverse events
were unrelated. There was no signal that patients allocated to intervention
did better than controls. Twenty five of 35 recruited carers provided
outcomes with excellent data completeness. Therapists, patients and carers
found prism adaptation training acceptable.